Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6661635 | 1.00 | ATM (0.73) | ATMHCAR2HPGDTSHRMAPT | |
| (2E)-Hexenoic Acid SCHEMBL29091197 | 0.94 | HCAR2 (0.73) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL21065507 | 0.92 | HCAR2 (0.71) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL11825924 | 0.92 | HCAR2 (0.71) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL11825918 | 0.92 | HCAR2 (0.71) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL18339405 | 0.92 | HCAR2 (0.71) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL18339407 | 0.92 | HCAR2 (0.71) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL1876004 | 0.92 | ATM (0.73) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL11843058 | 0.92 | ATM (0.73) | ATMHCAR2HPGDTSHRMAPT | |
| SCHEMBL10481292 | 0.90 | ATM (0.70) | ATMHCAR2HPGDTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117945887-A | Preparation method of milbelin intermediate (2E) -4-ethylheptyl-2, 6-dienoic acid | 山东新时代药业有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-8304581-B2 | Method of enantioselective addition to enones | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-11-06 | — | — | US | disclosed |
| US-20110282101-A1 | METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-17 | — | — | US | disclosed |
| EP-1123915-B1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | NIPPON CATALYTIC CHEM IND (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-6541656-B2 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY, LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20010034300-A1 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1123915-A1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | Nippon Shokubai Co., Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
| US-5008432-A | Reacting olefinically unsaturated compounds such as esters, acids, ketones, nitriles, carbamates, nitro and sulfoxides with hydrogen sulfide in presence of magnesium oxide catalyst | PHILLIPS PETROLEUM COMPANY (US) | 1991-04-16 | — | — | US | disclosed |
| EP-0208323-B1 | SULPHUR COMPOUND PRODUCTION | PHILLIPS PETROLEUM COMPANY (US) | 1991-03-06 | — | — | EP | disclosed |
| EP-0208323-A1 | Sulphur compound production | PHILLIPS PETROLEUM COMPANY (US) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282101-A1 | METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES | CPNE4, ENY2, CYP3A4 | ATM 4196/4885HCAR2 4470/4885HPGD 3449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.